Donna Lenox SW

Recommended Articles

• What Are the Signs and Symptoms of Stroke?

  Stroke can occur at any time of your life. However, those who have attained 65+ years are more prone to getting a stroke. It is also important to note that other factors such as family history, alcohol, smoking, medical history, and your ethnicity can trigger the occurrence of stroke. If you think...

• What Is Hyperalgesia?

  Introduction Can you imagine having a small bruise but feel like someone has hit you with a sledgehammer? If you can imagine the scenario or may have even felt it at some point in your life, then you must know what it's like to have hyperalgesia.Hyperalgesia is a medical term, which means that the...

• Rapid Shallow Breathing (Tachypnea): Causes and Treatments

  What is rapid shallow breathing?Rapid, shallow breathing, also medically called as tachypnea, is a term used to describe a breathing that is too fast, particularly when people have it due to a lung disease or other health conditions. Sometimes, rapid, shallow breathing and hyperventilation...

• Can Sleep Apnea Increase the Risk of Suicide?

  The national survey seems to indicate that those living with sleep apnea are at a higher risk of suicide. Because those affected by sleep apnea are more probable to idealize suicide, plan it, or see it as an option, this makes an early diagnosis of sleep apnea as an opportunity to prevent suicide...

• Does the Sun Really Help Treat Eczema?

  For a long time, it has been part of cultural knowledge that exposure to sunlight can help treat eczema. Now, it is medically agreed that eczema can be treated using UV light. But does this mean that you should go out and get yourself sunburnt?To answer this question, first, you have to consider the...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...